Takeda Pharmaceutical TAK
NYSE TAK
$18.27 -0.07 (-0.35%)
At close: Aug 20, 2026 · 11:58 AM UTC

Takeda Pharmaceutical (TAK) Net Margin Growth (1y) (2018 - 2026)

Takeda Pharmaceutical (TAK) Net Margin Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Haleon 44.07 Bn 43.10 Bn - -
2 Teva Pharmaceutical Industries 43.41 Bn 39.75 Bn 2.15 Bn -2,064.00
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn -177.00
4 Takeda Pharmaceutical 28.77 Bn 22.97 Bn 5.10 Bn -195.00
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 376.00
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -303.00
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn -58.00
8 Elanco Animal Health 11.93 Bn 11.40 Bn 798.00 Mn 306.00
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn - -
10 Alkermes 8.20 Bn 7.55 Bn 397.90 Mn -2,219.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -195.00
Mar 31, 2026 -10.00
Dec 31, 2025 -2,387.00
Sep 30, 2025 14.00
Jun 30, 2025 334.00
Mar 31, 2025 240.00
Dec 31, 2024 -1,276.00
Sep 30, 2024 -292.00
Jun 30, 2024 -56.00
Mar 31, 2024 -204.00
Dec 31, 2023 -790.00
Sep 30, 2023 274.00
Jun 30, 2023 -235.00
Mar 31, 2023 1,109.00
Dec 31, 2022 445.00
Sep 30, 2022 72.00
Jun 30, 2022 -370.00
Mar 31, 2022 -2,676.00
Dec 31, 2021 -463.00
Sep 30, 2021 493.00